Global Radiodermatitis Market Size, Trends & Growth Opportunity By Product (Oral, and Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Forecast till 2027

Global Radiodermatitis Market Size, Trends, & Growth Opportunity by Product (Oral, Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, and Forecast till 2027.

Global Radiodermatitis Market

The global radiodermatitis market was valued at USD 4362.5 million in 2021 which is expected to reach USD 674.22 million by 2027, at a CAGR 9.09 % from 2022-2027.

Radiation dermatitis, X-ray dermatitis, and radiation injury are all names for radiodermatitis. It is an unintended consequence of external beam ionising radiation. Radiotherapy is used to treat cancer or other disorders, which is the most common cause of radiothermatitis.

Market Drivers

The rise in cancer prevalence is the primary driving factor projected to increase the worldwide radiodermatitis market's growth. For example, the American Cancer Society estimates that in 2019, around 1,762,450 cancer cases will be identified and approximately 606,880 cancer deaths will occur in the United States. Furthermore, increased research & development of new medicines for radiodermatitis therapy will positively benefit global radiodermatitis market growth. Furthermore, investments in raising awareness about radiation-induced skin damage are likely to fuel the worldwide radiodermatitis market's expansion.

Market Restraints

However, the high cost of dressings such as honey-impregnated dressing and silicone dressing is projected to limit the worldwide radiodermatitis market's growth.

Market Segmentation

Global Radiodermatitis Market is segmented into products such as topical (corticosteroids, hydrophilic creams, antibiotics, and others), Oral, and Dressings (No Sting barrier film, Silicone Coated dressings, Honey impregnated gauze, and Others). Further, Global Radiodermatitis Market is segmented into distribution channel such as Hospital Pharmacy, Retail Pharmacy, and Others.

Regional analysis

Also, Global Radiodermatitis Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

Market Key Players

Various key players are discussed in this report, such as Jay Pharma, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., Molnlycke Health Care, Intermed Pharmaceuticals, DermaSciences, Inc., ConvaTec Group PLC, BMG Pharma S.r.l., and Acelity, Inc. (3M).

Market Taxonomy

By Product TopicalCorticosteroidsHydrophilic CreamsAntibioticsOthers Oral DressingsNo Sting barrier film Silicone Coated dressings Honey impregnated gauze OthersBy Distribution Channel Hospital Pharmacy Retail Pharmacy OthersBy Region North America Latin America Europe Asia Pacific Middle East & Africa